<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2017-06-23" updated="2020-01-02">
  <drugbank-id primary="true">DB13813</drugbank-id>
  <name>Iodoform</name>
  <description>Iodoform is an organoiodine compound with the formula CHI3 and a tetrahedral molecular geometry. It is a relatively water-insoluble yellow solid that is chemically reactive in free-radical reactions [A32890]. Due to its antimicrobial properties following topical administration, minimal levels of iodoform may be found in disinfectants and it is more primarily used for veterinary purposes. Iodoform has also been found in dental paste and root canal filling materials in combination with other intracanal medications due to its radiopacity [A32893]. Since the beginning of the 20th century, iodoform has been commonly used as a healing and antiseptic dressing or powder for wounds and sores, however such clinical use to this date is limited. Iodoform is soluble in fatty acids and decomposes releasing iodine in nascent state (96,7% of iodine) when in contact with secretions or endodontic infections [A32893].</description>
  <cas-number>75-47-8</cas-number>
  <unii>KXI2J76489</unii>
  <average-mass>393.732</average-mass>
  <monoisotopic-mass>393.72124</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>experimental</group>
    <group>vet_approved</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A32890</ref-id>
        <pubmed-id>5768872</pubmed-id>
        <citation>Sell DA, Reynolds ES: Liver parenchymal cell injury. 8. Lesions of membranous cellular components following iodoform. J Cell Biol. 1969 Jun;41(3):736-52.</citation>
      </article>
      <article>
        <ref-id>A32893</ref-id>
        <pubmed-id>19089027</pubmed-id>
        <citation>Estrela C, Estrela CR, Hollanda AC, Decurcio Dde A, Pecora JD: Influence of iodoform on antimicrobial potential of calcium hydroxide. J Appl Oral Sci. 2006 Jan;14(1):33-7.</citation>
      </article>
      <article>
        <ref-id>A32894</ref-id>
        <pubmed-id>22791151</pubmed-id>
        <citation>Mizokami F, Murasawa Y, Furuta K, Isogai Z: Iodoform gauze removes necrotic tissue from pressure ulcer wounds by fibrinolytic activity. Biol Pharm Bull. 2012;35(7):1048-53.</citation>
      </article>
      <article>
        <ref-id>A32895</ref-id>
        <pubmed-id>23123069</pubmed-id>
        <citation>Petel R, Moskovitz M, Tickotsky N, Halabi A, Goldstein J, Houri-Haddad Y: Cytotoxicity and proliferative effects of Iodoform-containing root canal-filling material on RAW 264.7 macrophage and RKO epithelial cell lines. Arch Oral Biol. 2013 Jan;58(1):75-81. doi: 10.1016/j.archoralbio.2012.06.014. Epub 2012 Nov 1.</citation>
      </article>
      <article>
        <ref-id>A32896</ref-id>
        <pubmed-id>23372860</pubmed-id>
        <citation>Fujiwara T, Hosokawa K, Kubo T: Comparative study of antibacterial effects and bacterial retentivity of wound dressings. Eplasty. 2013;13:e5. Epub 2013 Jan 24.</citation>
      </article>
    </articles>
    <textbooks/>
    <links>
      <link>
        <ref-id>L2646</ref-id>
        <title>IODOFORM - National Library of Medicine HSDB Database - Toxnet - NIH</title>
        <url>https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb%3A%40term+%40DOCNO+4099</url>
      </link>
    </links>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication>No approved therapeutic indications. </indication>
  <pharmacodynamics>Iodoform exhibits antibacterial activities after topical application. In a comparative study of wound dressing agents, iodoform gauze exerted an antibacterial effect 3 hours after the start of bacterial growth of _E. coli_ and subsequently maintained the strong antibacterial effectiveness [A32896]. A study demonstrated that direct and indirect exposure to high concentrations of iodoform induces a cytotoxic effect on cultures of macrophages and epithelial cells _in vitro_, while cell proliferation was enhanced at low concentrations of iodoform [A32895]. This cytotoxic effect of iodoform in root canals may further lead to long-term local irritation to follicles of permanent successors and formation of cyst-like radiolucent defects [A32895].</pharmacodynamics>
  <mechanism-of-action>While the mechanism of action of iodoform remains unclear, it is proposed that iodoform releases iodine, which denatures bacterial proteins by oxidation of the free iodine [A32896]. Iodoform may also play a role in chemical debridement for effective necrotic wound healing and tissue damage repair via collagen fibrinolysis; upon treatment in necrotic tissue, iodoform reduced the size of the macromolecules containing collagen I in wound surface proteins [A32894]. In human gingival fibroblasts _in vitro_, high concentrations of iodoform was shown to decrease the viability of macrophages and epithelial cells and reduced the secretion of _P. gingivalis_-induced TNFÎ± [A32895]. P. gingivalis is an anaerobic bacteria present in anaerobic oral niches including periapical sites and periodontal pockets [A32895]. </mechanism-of-action>
  <toxicity>Oral LD50, dermal LD50, and inhalation LC50 in rat are 355 mg/kg, 1184 mg/kg, and 165 ppm/7h, respectively [MSDS]. Fatal dose of iodoform in humans is estimated to be 2 g [L2646]. Systemic intoxication and severe poisoning, mostly characterized by dermatitis, headache, somnolence, delirium, hallucinations, consciousness disturbances, coma, vomiting, CNS depression, tachycardia, and rapid feeble pulse, may result from excess absorption through wounds and abscesses, or ingestion of large quantities [L2646]. While there is no known antidote for iodoform overdose, supportive and symptomatic treatment is highly recommended [L2646]. &#13;
&#13;
Hepatocellular damage has been observed with iodoform toxicity, where production of both fatty liver and necrosis was seen, as well as lesions of liver membranous cellular components [L2646]. Iodoform induces hepatocellular injury and hepatic lesions in a similar manner to carbon tetrachloride, where cellular membranes may possibly be primary sites of action [A32890]. </toxicity>
  <metabolism>It is expected to be oxidized to iodine [L2646].</metabolism>
  <absorption>Iodoform is reported to be absorbed through denuded skin, wounds or mucous membranes [L2646]. </absorption>
  <half-life>No pharmacokinetic data available. </half-life>
  <protein-binding>No pharmacokinetic data available. </protein-binding>
  <route-of-elimination>No pharmacokinetic data available. </route-of-elimination>
  <volume-of-distribution>No pharmacokinetic data available. </volume-of-distribution>
  <clearance>No pharmacokinetic data available. </clearance>
  <classification>
    <description>This compound belongs to the class of organic compounds known as trihalomethanes. These are organic compounds in which exactly three of the four hydrogen atoms of methane (CH4) are replaced by halogen atoms.</description>
    <direct-parent>Trihalomethanes</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Organohalogen compounds</superclass>
    <class>Alkyl halides</class>
    <subclass>Halomethanes</subclass>
    <alternative-parent>Alkyl iodides</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>Organoiodides</alternative-parent>
    <substituent>Aliphatic acyclic compound</substituent>
    <substituent>Alkyl iodide</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Organoiodide</substituent>
    <substituent>Trihalomethane</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">carbon triiodide</synonym>
    <synonym language="english" coder="">Jodoform</synonym>
    <synonym language="english" coder="">methyl triiodide</synonym>
    <synonym language="english" coder="">triiodomethane</synonym>
  </synonyms>
  <products>
    <product>
      <name>Curity 3% Iodoform Packing Strip</name>
      <labeller>Tyco Healthcare</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02155044</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2010-08-05</ended-marketing-on>
      <dosage-form>Dressing</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Iodoform Nugauze Packing Strip 5%</name>
      <labeller>Johnson &amp; Johnson Medical Products</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01938312</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1992-12-31</started-marketing-on>
      <ended-marketing-on>2003-08-13</ended-marketing-on>
      <dosage-form>Dressing</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Iodoform Packing Strip</name>
      <labeller>Derma Sciences Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02258757</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2005-03-03</started-marketing-on>
      <ended-marketing-on>2019-02-08</ended-marketing-on>
      <dosage-form>Strip</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Iodoform Packing Strip 5% W/w</name>
      <labeller>Dumex Medical Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02239837</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2002-03-11</started-marketing-on>
      <ended-marketing-on>2005-08-09</ended-marketing-on>
      <dosage-form>Strip</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Iodoform Packing Strip</name>
      <ingredients>Iodoform</ingredients>
    </mixture>
    <mixture>
      <name>Iodoform Nugauze Packing Strip 5%</name>
      <ingredients>Iodoform</ingredients>
    </mixture>
    <mixture>
      <name>Curity 3% Iodoform Packing Strip</name>
      <ingredients>Iodoform</ingredients>
    </mixture>
    <mixture>
      <name>Iodoform Packing Strip 5% W/w</name>
      <ingredients>Iodoform</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Dermatologicals</category>
      <mesh-id>D003879</mesh-id>
    </category>
    <category>
      <category>Hydrocarbons, Halogenated</category>
      <mesh-id>D006846</mesh-id>
    </category>
    <category>
      <category>Medicated Dressings</category>
      <mesh-id/>
    </category>
    <category>
      <category>Medicated Dressings With Antiinfectives</category>
      <mesh-id/>
    </category>
    <category>
      <category>Miscellaneous Local Anti-infectives</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Dressing</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Strip</form>
      <route>Topical</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="D09AA13">
      <level code="D09AA">Medicated dressings with antiinfectives</level>
      <level code="D09A">MEDICATED DRESSINGS</level>
      <level code="D09">MEDICATED DRESSINGS</level>
      <level code="D">DERMATOLOGICALS</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes>
    <ahfs-code>84:04.92</ahfs-code>
  </ahfs-codes>
  <pdb-entries/>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB13813.pdf?1525363036</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>2.82</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-3.4</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>1.43e-01 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>4.65</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>triiodomethane</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>iodoform</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>393.732</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>393.72124</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>[H]C(I)(I)I</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>CHI3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/CHI3/c2-1(3)4/h1H</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>OKJPEAGHQZHRQV-UHFFFAOYSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>45.24</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>17.59</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>Slightly soluble</value>
      <source>MSDS</source>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>119-122</value>
      <source>MSDS</source>
    </property>
    <property>
      <kind>Boiling Point</kind>
      <value>218</value>
      <source>MSDS</source>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>10011</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>37758</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>6374</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>347829319</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C13383</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D01910</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>6134</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Iodoform</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL1451116</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions>
    <reaction>
      <sequence>1</sequence>
      <left-element>
        <drugbank-id>DB13813</drugbank-id>
        <name>Iodoform</name>
      </left-element>
      <right-element>
        <drugbank-id>DB05382</drugbank-id>
        <name>Iodine</name>
      </right-element>
      <enzymes/>
    </reaction>
  </reactions>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>